Previous Article | Next Article ![]()
Journal of Clinical Microbiology, 06 1995, 1628-1631, Vol 33, No. 6
PN Goldwater
An immunoglobulin M (IgM) capture enzyme immunoassay was used to detect
major overlapping outbreaks of disease in South Australia caused by
coxsackieviruses B5 (CBV-5) and B6 (CBV-6). CBV-5-specific IgM was detected
in patients presenting in spring 1992 with acute febrile illnesses, rash,
severe acute respiratory disease, meningitis, myocarditis and/or
pericarditis, while tests for other viruses were negative. CBV-5 was
isolated from an early case. In December 1992 it was noted that CBV-6 had
replaced CBV-5 as the major cause of disease. The CBV-6 epidemic continued
until April 1993. Serum samples from 495 patients (276 inpatients) were
submitted for testing. CBV-6 infection was associated with lower
respiratory tract infection and persistent cough. This study demonstrated
success of the IgM enzyme immunoassay and the need for diagnostic virology
laboratories to look for CBV-6 infection in addition to the other five
CBVs.
Copyright © 1995 by the American Society for Microbiology. All rights reserved.
Immunoglobulin M capture immunoassay in investigation of coxsackievirus B5 and B6 outbreaks in South Australia
Microbiology and Infectious Disease Service, Women's and Children's Hospital, North Adelaide, Australia.
This article has been cited by other articles:
| Antimicrob. Agents Chemother. | Clin. Microbiol. Rev. |
|---|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|